Bronchiectasis in India: results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry
This study provides a benchmark to improve quality of care for patients with bronchiectasis in India.FundingEU/European Federation of Pharmaceutical Industries and Associations Innovative Medicines Initiative inhaled Antibiotics in Bronchiectasis and Cystic Fibrosis Consortium, European Respiratory Society, and the British Lung Foundation.
Source: The Lancet Global Health - Category: International Medicine & Public Health Source Type: research
More News: Allergy & Immunology | Aspergillosis | Cystic Fibrosis | Epidemiology | India Health | International Medicine & Public Health | Microbiology | Research | Respiratory Medicine | Study | Tuberculosis | UK Health